Antipsychotics and diabetes: Review of non-prospective data
- 1 April 2004
- journal article
- review article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 184 (S47) , s80-s86
- https://doi.org/10.1192/bjp.184.47.s80
Abstract
Background: Much of the existing data regarding the relationship between antipsychotic medications and diabetes mellitus are non-prospective.Aims: To review critically non-prospective studies examining antipsychotic medications as risk factors for diabetes mellitus.Method: Database and manual searches.Results: Anecdotal reports indicate that conventional and atypical antipsychotics can cause diabetes mellitus. However, retrospective studies cannot reliably quantify this association, as they do not adequately control for confounding risk factors for diabetes, or for variation in detection and diagnosis of this illness. Most studies report a higher rate of diabetes in patients who use antipsychotic medication than in non-users, and in patients taking atypical v. conventional antipsychotics. Studies assessing the relative risks of diabetes between individual atypical antipsychotics are contradictory.Conclusions: Retrospective data are of limited value. Well-designed prospective studies, which account for potential confounders, are needed to investigate the true association between antipsychotic medications and diabetes.Keywords
This publication has 28 references indexed in Scilit:
- P.2.063 Antipsychotic medication treatment and new prescriptions for insulin and oral hypoglycemicsEuropean Neuropsychopharmacology, 2003
- Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With SchizophreniaAmerican Journal of Psychiatry, 2003
- A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United StatesJournal of Clinical Epidemiology, 2003
- Assessing the risk of antipsychotic-induced Type II diabetes among schizophrenics: A matched case-control studyEuropean Neuropsychopharmacology, 2002
- Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 DiabetesThe Journal of Clinical Psychiatry, 2002
- PDB2 A RETROSPECTIVE COHORT STUDY OF DIABETES MELLITUS AND ANTIPSYCHOTIC TREATMENT IN THE UNITED KINGDOMValue in Health, 2002
- Physical consequences of schizophrenia and its treatmentLife Sciences, 2002
- Increased visceral fat distribution in drug-naive and drug-free patients with schizophreniaInternational Journal of Obesity, 2002
- Glucose Intolerance with Atypical AntipsychoticsDrug Safety, 2002